Development of cancer cooperative groups in Japan

Japanese Journal of Clinical Oncology

Volumn 40, Issue 9, 2010, Pages 881-890

  Fukuda, Haruhiko ^a  

^a NATIONAL CANCER CENTER   (Japan)

Author keywords

Cancer; Cooperative group; Linical trials; Therapeutic development

Indexed keywords

ANTINEOPLASTIC AGENT; CHLORMETHINE; MERCAPTOPURINE; METHOTREXATE; THIOTEPA;

ACUTE LEUKEMIA; CANCER CENTER; CANCER COMBINATION CHEMOTHERAPY; CANCER THERAPY; DEVELOPMENT; HEALTH CARE ORGANIZATION; INTERNATIONAL STANDARD UNIT; JAPAN; MEDICAL LITERATURE; NATIONAL HEALTH ORGANIZATION; QUALITY CONTROL; REVIEW; STATISTICAL ANALYSIS; TREATMENT PLANNING; CLINICAL TRIAL (TOPIC); HUMAN; MULTICENTER STUDY (TOPIC); NEOPLASMS; ONCOLOGY; PROCEDURES; STANDARDS; TRENDS; UNITED STATES;

CLINICAL TRIALS AS TOPIC; HUMANS; JAPAN; MEDICAL ONCOLOGY; MULTICENTER STUDIES AS TOPIC; NEOPLASMS; UNITED STATES;

EID: 77956152969     PISSN: 03682811     EISSN: 14653621     Source Type: Journal    
DOI: 10.1093/jjco/hyq135     Document Type: Review

References (23)

1. The Editorial Board of the Cancer Statistics in Japan. Trend in Crude Mortality Rate for Leading Cause of Death (1947-2007). Cancer Statistics in Japan-2009. Tokyo: Foundation for Promotion of Cancer Research, 2009;24.
2. The Editorial Board of the Cancer Statistics in Japan. International Comparisons of Cancer Survival Rates. Cancer Statistics in Japan-2009. Tokyo: Foundation for Promotion of Cancer Research 2009;46.
3. Kola I, Landis J. Can the pharmaceutical industry reduce attrition rates? Nat Rev Drug Discov 2004;3:711-5.
4. Nass SJ, Moses HL,, Mendelsohn J. A National Cancer Clinical Trials System for the 21st Century: Reinvigorating the NCI Cooperative Group Program. Editors; Committee on Cancer Clinical Trials and the NCI Cooperative Group Program; Institute of Medicine. http://www.nap.edu/catalog/12879.html.
5. Booth CM, Cescon DW, Wang L, Tannock IF, Krzyzanowska MK. Evolution of the randomized controlled trial in oncology over three decades. J Clin Oncol 2008;26:5458-64.
6. Gehan EA,, Schneiderman MA. Historical and methodological developments in clinical trials at the National Cancer Institute. Stat Med 1990;9:871-80.
7. NCI's Clinical Trials Cooperative Group Program. http://ctep.cancer.gov/investigatorResources/docs/coopgrpguidelines.pdf.
8. Carbone PP, Tormey DC. Organizing multicenter trials: lessons from the cooperative oncology groups. Prev Med 1991;20:162-9.
9. The National Cancer Institute. Cancer Clinical Trials: The Basic Workbook. http://www.cancer.gov/clinicaltrials/resources/basicworkbook.
10. Simon R. A decade of progress in statistical methodology for clinical trials. Stat Med 1991;10:1789-817.
11. Green S, Benedetti J, Crowley J. Interim analysis and data monitoring committees. In: Clinical Trials in Oncology. 2nd edn. Boca Raton: Chapman & Hall/CRC 2003;97-122.
12. Sargent DJ, Conley BA, Allegra C, Collette L. Clinical trial designs for predictive marker validation in cancer treatment trials. J Clin Oncol 2005;23:2020-7.
13. Mandrekar SJ,, Sargent DJ. Clinical trial designs for predictive biomarker validation: theoretical considerations and practical challenges. J Clin Oncol 2009;27:4027-34.
14. Trimble EL, Abrams JS, Meyer RM, Calvo F, Cazap E, Deye J, et al., Improving cancer outcomes through international collaboration in academic cancer treatment trials. J Clin Oncol 2009;27:5109-14.
15. Shimoyama M, Fukuda H, Saijo N, Yamaguchi N and the member of the Committees for the Japan Clinical Oncology Group (JCOG). Japan Clinical Oncology Group (JCOG). Jpn J Clin Oncol 1998;23:158-62.
16. Lan KKG, DeMets DL. Discrete sequential boundaries for clinical trials. Biometrika 1983;70:659-63.
17. Shimoyama M, Tajima K, Ohashi Y. Development of a computerized system, JCOG Statistical Center, for the management and analysis of data from JCOG clinical trials. Gann No Rinshyo 1997;43:87-116 (in Japanese).
18. The International Conference on Harmonisation of Technical Requirements for Registration of Pharmaceuticals for Human Use (ICH). http://www.ich.org/cache/compo/276-254-1.html.
19. Guidelines for Monitoring of Clinical Trials for Cooperative Groups, CCOP Research Bases, and the Cancer Trials Support Unit (CTSU). http://ctep.cancer.gov/branches/ctmb/clinicalTrials/monitoring.htm.
20. Dilts DM, Sandler AB, Baker M, Cheng SK, George SL, Karas KS, et al., Processes to activate phase III clinical trials in a cooperative oncology group: the case of cancer and leukemia group B. J Clin Oncol 2006;24:4553-557.
21. Dilts DM, Sandler A, Cheng S, Crites J, Ferranti L, Wu A, et al., Development of clinical trials in a cooperative group setting: the Eastern Cooperative Oncology Group. Clin Cancer Res 2008;14:3427-33.
22. National Cancer Institute. Report of the National Cancer Institute Clinical Trials Program Review Group. 1997. http://deainfo.nci.nih.gov/ADVISORY/bsa/bsa_program/bsactprgmin.htm#8a.
23. National Cancer Institute. Restructuring the national cancer clinical trials enterprise. Report of the Clinical Trials Working Group of the National Cancer Advisory Board. Bethesda, MD: National Cancer Institute.